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Abstract 
Introduction: Depression and anxiety disorders have been found to be highly comorbid in 
epidemiologic studies. Furthermore, the presence of the short allele of the serotonin transporter 
gene (5HTT) has been found to be associated with an increased prevalence of major 
depressive disorder (MDD), bipolar disorder, anxiety disorders, as well as personality disorders. 
Aims: To examine the association of the 5HTT and the risk of prevalence and comorbidity for, 
Major Depressive Disorder, Bipolar Disorder, as well as several anxiety disorders in a sample of 
the Baltimore Epidemiologic Catchment Area Survey Follow-up Study.  
Methods: We estimated lifetime prevalence and the risk of comorbidity for Major Depressive 
Disorder, Bipolar Disorder, Panic Disorder, Agoraphobia, Social Phobia, Obsessive Compulsive 
Disorder, Generalized Anxiety Disorder, Simple Phobia, Dysthymic Disorder. All subjects were 
evaluated by a psychiatrist using the Schedules for Clinical Assessment in Neuropsychiatry. In 
addition, we assessed the impact of the carrier status into the prevalence and comorbidity 
estimates of the aforementioned disorders.  
Results:  A significant association was found between an increased risk for the lifetime 
prevalence of Panic Disorder and the 5-HTT “s” polymorphism (OR (95% CI): 3.10 (1.33; 7.27). 
A higher risk for lifetime prevalence of Panic Disorder and the 5-HTT “s” polymorphism  was 
found in women carriers as compared to men(OR (95% CI): 3.54 (1.41; 8.91)). Panic Disorder 
had significant comorbidities with Alcohol Dependence, Alcohol Abuse, MDD, Bipolar Disorder, 
Agoraphobia, Social Phobia, OCD, Simple Phobia and Adjustment Disorder. These associations 
were higher in women as compared to men carriers. Comorbidities for Simple Phobia were 
highly significant in males for most anxiety disorders and MDD.  
Conclusions: There was a high prevalence of comorbidity amongst most of the anxiety disorders 
in this population. The effect of the 5HTT carrier status was only associated with an increment in 
the risk of having a Panic Disorder. 
 
